Observatory of Prolymphocytic Leukemia T

Plain-language summary

This observational study aims to characterize the molecular features of T-cell prolymphocytic leukemia. Men and women aged 18 and over with this diagnosis are eligible. It is a non-phase observational study and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

French Innovative Leukemia Organisation

Intervention

Molecular caracterization

Start date

7/1/2020

Estimated completion

7/30/2028

Countries

France

Related genes

Locations

• Le Mans, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Man or woman aged 18 or over
* Patient with prolymphocytic T leukemia

Exclusion Criteria:

* Absence of signature of informed consent